Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

Artificial Knee Joint Market

ID: MRFR/HC/33376-HCR
100 Pages
Rahul Gotadki
Last Updated: April 06, 2026
Artificial Knee Joint Market Research Report: Size, Share, Trend Analysis By Material Type (Metal, Ceramic, Plastic), By Implant Type (Total Knee Replacement, Partial Knee Replacement, Patellofemoral Replacement), By Patient Age Group (Under 30, 30-60, Over 60), By Product Design (Fixed Bearing, Mobile Bearing, Cruciate Retaining) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Growth Outlook & Industry Forecast 2025 To 2035
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
    1. 1.1 EXECUTIVE SUMMARY
      1. 1.1.1 Market Overview
      2. 1.1.2 Key Findings
      3. 1.1.3 Market Segmentation
      4. 1.1.4 Competitive Landscape
      5. 1.1.5 Challenges and Opportunities
      6. 1.1.6 Future Outlook
  2. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
    1. 2.1 MARKET INTRODUCTION
      1. 2.1.1 Definition
      2. 2.1.2 Scope of the study
        1. 2.1.2.1 Research Objective
        2. 2.1.2.2 Assumption
        3. 2.1.2.3 Limitations
    2. 2.2 RESEARCH METHODOLOGY
      1. 2.2.1 Overview
      2. 2.2.2 Data Mining
      3. 2.2.3 Secondary Research
      4. 2.2.4 Primary Research
        1. 2.2.4.1 Primary Interviews and Information Gathering Process
        2. 2.2.4.2 Breakdown of Primary Respondents
      5. 2.2.5 Forecasting Model
      6. 2.2.6 Market Size Estimation
        1. 2.2.6.1 Bottom-Up Approach
        2. 2.2.6.2 Top-Down Approach
      7. 2.2.7 Data Triangulation
      8. 2.2.8 Validation
  3. 3 SECTION III: QUALITATIVE ANALYSIS
    1. 3.1 MARKET DYNAMICS
      1. 3.1.1 Overview
      2. 3.1.2 Drivers
      3. 3.1.3 Restraints
      4. 3.1.4 Opportunities
    2. 3.2 MARKET FACTOR ANALYSIS
      1. 3.2.1 Value chain Analysis
      2. 3.2.2 Porter's Five Forces Analysis
        1. 3.2.2.1 Bargaining Power of Suppliers
        2. 3.2.2.2 Bargaining Power of Buyers
        3. 3.2.2.3 Threat of New Entrants
        4. 3.2.2.4 Threat of Substitutes
        5. 3.2.2.5 Intensity of Rivalry
      3. 3.2.3 COVID-19 Impact Analysis
        1. 3.2.3.1 Market Impact Analysis
        2. 3.2.3.2 Regional Impact
        3. 3.2.3.3 Opportunity and Threat Analysis
  4. 4 SECTION IV: QUANTITATIVE ANALYSIS
    1. 4.1 Healthcare, BY Material Type (USD Billion)
      1. 4.1.1 Metal
      2. 4.1.2 Ceramic
      3. 4.1.3 Plastic
    2. 4.2 Healthcare, BY Implant Type (USD Billion)
      1. 4.2.1 Total Knee Replacement
      2. 4.2.2 Partial Knee Replacement
      3. 4.2.3 Patellofemoral Replacement
    3. 4.3 Healthcare, BY Patient Age Group (USD Billion)
      1. 4.3.1 Under 30
      2. 4.3.2 30-60
      3. 4.3.3 Over 60
    4. 4.4 Healthcare, BY Product Design (USD Billion)
      1. 4.4.1 Fixed Bearing
      2. 4.4.2 Mobile Bearing
      3. 4.4.3 Cruciate Retaining
    5. 4.5 Healthcare, BY Region (USD Billion)
      1. 4.5.1 North America
        1. 4.5.1.1 US
        2. 4.5.1.2 Canada
      2. 4.5.2 Europe
        1. 4.5.2.1 Germany
        2. 4.5.2.2 UK
        3. 4.5.2.3 France
        4. 4.5.2.4 Russia
        5. 4.5.2.5 Italy
        6. 4.5.2.6 Spain
        7. 4.5.2.7 Rest of Europe
      3. 4.5.3 APAC
        1. 4.5.3.1 China
        2. 4.5.3.2 India
        3. 4.5.3.3 Japan
        4. 4.5.3.4 South Korea
        5. 4.5.3.5 Malaysia
        6. 4.5.3.6 Thailand
        7. 4.5.3.7 Indonesia
        8. 4.5.3.8 Rest of APAC
      4. 4.5.4 South America
        1. 4.5.4.1 Brazil
        2. 4.5.4.2 Mexico
        3. 4.5.4.3 Argentina
        4. 4.5.4.4 Rest of South America
      5. 4.5.5 MEA
        1. 4.5.5.1 GCC Countries
        2. 4.5.5.2 South Africa
        3. 4.5.5.3 Rest of MEA
  5. 5 SECTION V: COMPETITIVE ANALYSIS
    1. 5.1 Competitive Landscape
      1. 5.1.1 Overview
      2. 5.1.2 Competitive Analysis
      3. 5.1.3 Market share Analysis
      4. 5.1.4 Major Growth Strategy in the Healthcare
      5. 5.1.5 Competitive Benchmarking
      6. 5.1.6 Leading Players in Terms of Number of Developments in the Healthcare
      7. 5.1.7 Key developments and growth strategies
        1. 5.1.7.1 New Product Launch/Service Deployment
        2. 5.1.7.2 Merger & Acquisitions
        3. 5.1.7.3 Joint Ventures
      8. 5.1.8 Major Players Financial Matrix
        1. 5.1.8.1 Sales and Operating Income
        2. 5.1.8.2 Major Players R&D Expenditure. 2023
    2. 5.2 Company Profiles
      1. 5.2.1 Zimmer Biomet (US)
        1. 5.2.1.1 Financial Overview
        2. 5.2.1.2 Products Offered
        3. 5.2.1.3 Key Developments
        4. 5.2.1.4 SWOT Analysis
        5. 5.2.1.5 Key Strategies
      2. 5.2.2 Stryker (US)
        1. 5.2.2.1 Financial Overview
        2. 5.2.2.2 Products Offered
        3. 5.2.2.3 Key Developments
        4. 5.2.2.4 SWOT Analysis
        5. 5.2.2.5 Key Strategies
      3. 5.2.3 DePuy Synthes (US)
        1. 5.2.3.1 Financial Overview
        2. 5.2.3.2 Products Offered
        3. 5.2.3.3 Key Developments
        4. 5.2.3.4 SWOT Analysis
        5. 5.2.3.5 Key Strategies
      4. 5.2.4 Smith & Nephew (GB)
        1. 5.2.4.1 Financial Overview
        2. 5.2.4.2 Products Offered
        3. 5.2.4.3 Key Developments
        4. 5.2.4.4 SWOT Analysis
        5. 5.2.4.5 Key Strategies
      5. 5.2.5 Medtronic (US)
        1. 5.2.5.1 Financial Overview
        2. 5.2.5.2 Products Offered
        3. 5.2.5.3 Key Developments
        4. 5.2.5.4 SWOT Analysis
        5. 5.2.5.5 Key Strategies
      6. 5.2.6 Ottobock (DE)
        1. 5.2.6.1 Financial Overview
        2. 5.2.6.2 Products Offered
        3. 5.2.6.3 Key Developments
        4. 5.2.6.4 SWOT Analysis
        5. 5.2.6.5 Key Strategies
      7. 5.2.7 B. Braun (DE)
        1. 5.2.7.1 Financial Overview
        2. 5.2.7.2 Products Offered
        3. 5.2.7.3 Key Developments
        4. 5.2.7.4 SWOT Analysis
        5. 5.2.7.5 Key Strategies
      8. 5.2.8 Exactech (US)
        1. 5.2.8.1 Financial Overview
        2. 5.2.8.2 Products Offered
        3. 5.2.8.3 Key Developments
        4. 5.2.8.4 SWOT Analysis
        5. 5.2.8.5 Key Strategies
      9. 5.2.9 Aesculap (DE)
        1. 5.2.9.1 Financial Overview
        2. 5.2.9.2 Products Offered
        3. 5.2.9.3 Key Developments
        4. 5.2.9.4 SWOT Analysis
        5. 5.2.9.5 Key Strategies
    3. 5.3 Appendix
      1. 5.3.1 References
      2. 5.3.2 Related Reports
  6. 6 LIST OF FIGURES
    1. 6.1 MARKET SYNOPSIS
    2. 6.2 NORTH AMERICA MARKET ANALYSIS
    3. 6.3 US MARKET ANALYSIS BY MATERIAL TYPE
    4. 6.4 US MARKET ANALYSIS BY IMPLANT TYPE
    5. 6.5 US MARKET ANALYSIS BY PATIENT AGE GROUP
    6. 6.6 US MARKET ANALYSIS BY PRODUCT DESIGN
    7. 6.7 CANADA MARKET ANALYSIS BY MATERIAL TYPE
    8. 6.8 CANADA MARKET ANALYSIS BY IMPLANT TYPE
    9. 6.9 CANADA MARKET ANALYSIS BY PATIENT AGE GROUP
    10. 6.10 CANADA MARKET ANALYSIS BY PRODUCT DESIGN
    11. 6.11 EUROPE MARKET ANALYSIS
    12. 6.12 GERMANY MARKET ANALYSIS BY MATERIAL TYPE
    13. 6.13 GERMANY MARKET ANALYSIS BY IMPLANT TYPE
    14. 6.14 GERMANY MARKET ANALYSIS BY PATIENT AGE GROUP
    15. 6.15 GERMANY MARKET ANALYSIS BY PRODUCT DESIGN
    16. 6.16 UK MARKET ANALYSIS BY MATERIAL TYPE
    17. 6.17 UK MARKET ANALYSIS BY IMPLANT TYPE
    18. 6.18 UK MARKET ANALYSIS BY PATIENT AGE GROUP
    19. 6.19 UK MARKET ANALYSIS BY PRODUCT DESIGN
    20. 6.20 FRANCE MARKET ANALYSIS BY MATERIAL TYPE
    21. 6.21 FRANCE MARKET ANALYSIS BY IMPLANT TYPE
    22. 6.22 FRANCE MARKET ANALYSIS BY PATIENT AGE GROUP
    23. 6.23 FRANCE MARKET ANALYSIS BY PRODUCT DESIGN
    24. 6.24 RUSSIA MARKET ANALYSIS BY MATERIAL TYPE
    25. 6.25 RUSSIA MARKET ANALYSIS BY IMPLANT TYPE
    26. 6.26 RUSSIA MARKET ANALYSIS BY PATIENT AGE GROUP
    27. 6.27 RUSSIA MARKET ANALYSIS BY PRODUCT DESIGN
    28. 6.28 ITALY MARKET ANALYSIS BY MATERIAL TYPE
    29. 6.29 ITALY MARKET ANALYSIS BY IMPLANT TYPE
    30. 6.30 ITALY MARKET ANALYSIS BY PATIENT AGE GROUP
    31. 6.31 ITALY MARKET ANALYSIS BY PRODUCT DESIGN
    32. 6.32 SPAIN MARKET ANALYSIS BY MATERIAL TYPE
    33. 6.33 SPAIN MARKET ANALYSIS BY IMPLANT TYPE
    34. 6.34 SPAIN MARKET ANALYSIS BY PATIENT AGE GROUP
    35. 6.35 SPAIN MARKET ANALYSIS BY PRODUCT DESIGN
    36. 6.36 REST OF EUROPE MARKET ANALYSIS BY MATERIAL TYPE
    37. 6.37 REST OF EUROPE MARKET ANALYSIS BY IMPLANT TYPE
    38. 6.38 REST OF EUROPE MARKET ANALYSIS BY PATIENT AGE GROUP
    39. 6.39 REST OF EUROPE MARKET ANALYSIS BY PRODUCT DESIGN
    40. 6.40 APAC MARKET ANALYSIS
    41. 6.41 CHINA MARKET ANALYSIS BY MATERIAL TYPE
    42. 6.42 CHINA MARKET ANALYSIS BY IMPLANT TYPE
    43. 6.43 CHINA MARKET ANALYSIS BY PATIENT AGE GROUP
    44. 6.44 CHINA MARKET ANALYSIS BY PRODUCT DESIGN
    45. 6.45 INDIA MARKET ANALYSIS BY MATERIAL TYPE
    46. 6.46 INDIA MARKET ANALYSIS BY IMPLANT TYPE
    47. 6.47 INDIA MARKET ANALYSIS BY PATIENT AGE GROUP
    48. 6.48 INDIA MARKET ANALYSIS BY PRODUCT DESIGN
    49. 6.49 JAPAN MARKET ANALYSIS BY MATERIAL TYPE
    50. 6.50 JAPAN MARKET ANALYSIS BY IMPLANT TYPE
    51. 6.51 JAPAN MARKET ANALYSIS BY PATIENT AGE GROUP
    52. 6.52 JAPAN MARKET ANALYSIS BY PRODUCT DESIGN
    53. 6.53 SOUTH KOREA MARKET ANALYSIS BY MATERIAL TYPE
    54. 6.54 SOUTH KOREA MARKET ANALYSIS BY IMPLANT TYPE
    55. 6.55 SOUTH KOREA MARKET ANALYSIS BY PATIENT AGE GROUP
    56. 6.56 SOUTH KOREA MARKET ANALYSIS BY PRODUCT DESIGN
    57. 6.57 MALAYSIA MARKET ANALYSIS BY MATERIAL TYPE
    58. 6.58 MALAYSIA MARKET ANALYSIS BY IMPLANT TYPE
    59. 6.59 MALAYSIA MARKET ANALYSIS BY PATIENT AGE GROUP
    60. 6.60 MALAYSIA MARKET ANALYSIS BY PRODUCT DESIGN
    61. 6.61 THAILAND MARKET ANALYSIS BY MATERIAL TYPE
    62. 6.62 THAILAND MARKET ANALYSIS BY IMPLANT TYPE
    63. 6.63 THAILAND MARKET ANALYSIS BY PATIENT AGE GROUP
    64. 6.64 THAILAND MARKET ANALYSIS BY PRODUCT DESIGN
    65. 6.65 INDONESIA MARKET ANALYSIS BY MATERIAL TYPE
    66. 6.66 INDONESIA MARKET ANALYSIS BY IMPLANT TYPE
    67. 6.67 INDONESIA MARKET ANALYSIS BY PATIENT AGE GROUP
    68. 6.68 INDONESIA MARKET ANALYSIS BY PRODUCT DESIGN
    69. 6.69 REST OF APAC MARKET ANALYSIS BY MATERIAL TYPE
    70. 6.70 REST OF APAC MARKET ANALYSIS BY IMPLANT TYPE
    71. 6.71 REST OF APAC MARKET ANALYSIS BY PATIENT AGE GROUP
    72. 6.72 REST OF APAC MARKET ANALYSIS BY PRODUCT DESIGN
    73. 6.73 SOUTH AMERICA MARKET ANALYSIS
    74. 6.74 BRAZIL MARKET ANALYSIS BY MATERIAL TYPE
    75. 6.75 BRAZIL MARKET ANALYSIS BY IMPLANT TYPE
    76. 6.76 BRAZIL MARKET ANALYSIS BY PATIENT AGE GROUP
    77. 6.77 BRAZIL MARKET ANALYSIS BY PRODUCT DESIGN
    78. 6.78 MEXICO MARKET ANALYSIS BY MATERIAL TYPE
    79. 6.79 MEXICO MARKET ANALYSIS BY IMPLANT TYPE
    80. 6.80 MEXICO MARKET ANALYSIS BY PATIENT AGE GROUP
    81. 6.81 MEXICO MARKET ANALYSIS BY PRODUCT DESIGN
    82. 6.82 ARGENTINA MARKET ANALYSIS BY MATERIAL TYPE
    83. 6.83 ARGENTINA MARKET ANALYSIS BY IMPLANT TYPE
    84. 6.84 ARGENTINA MARKET ANALYSIS BY PATIENT AGE GROUP
    85. 6.85 ARGENTINA MARKET ANALYSIS BY PRODUCT DESIGN
    86. 6.86 REST OF SOUTH AMERICA MARKET ANALYSIS BY MATERIAL TYPE
    87. 6.87 REST OF SOUTH AMERICA MARKET ANALYSIS BY IMPLANT TYPE
    88. 6.88 REST OF SOUTH AMERICA MARKET ANALYSIS BY PATIENT AGE GROUP
    89. 6.89 REST OF SOUTH AMERICA MARKET ANALYSIS BY PRODUCT DESIGN
    90. 6.90 MEA MARKET ANALYSIS
    91. 6.91 GCC COUNTRIES MARKET ANALYSIS BY MATERIAL TYPE
    92. 6.92 GCC COUNTRIES MARKET ANALYSIS BY IMPLANT TYPE
    93. 6.93 GCC COUNTRIES MARKET ANALYSIS BY PATIENT AGE GROUP
    94. 6.94 GCC COUNTRIES MARKET ANALYSIS BY PRODUCT DESIGN
    95. 6.95 SOUTH AFRICA MARKET ANALYSIS BY MATERIAL TYPE
    96. 6.96 SOUTH AFRICA MARKET ANALYSIS BY IMPLANT TYPE
    97. 6.97 SOUTH AFRICA MARKET ANALYSIS BY PATIENT AGE GROUP
    98. 6.98 SOUTH AFRICA MARKET ANALYSIS BY PRODUCT DESIGN
    99. 6.99 REST OF MEA MARKET ANALYSIS BY MATERIAL TYPE
    100. 6.100 REST OF MEA MARKET ANALYSIS BY IMPLANT TYPE
    101. 6.101 REST OF MEA MARKET ANALYSIS BY PATIENT AGE GROUP
    102. 6.102 REST OF MEA MARKET ANALYSIS BY PRODUCT DESIGN
    103. 6.103 KEY BUYING CRITERIA OF HEALTHCARE
    104. 6.104 RESEARCH PROCESS OF MRFR
    105. 6.105 DRO ANALYSIS OF HEALTHCARE
    106. 6.106 DRIVERS IMPACT ANALYSIS: HEALTHCARE
    107. 6.107 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE
    108. 6.108 SUPPLY / VALUE CHAIN: HEALTHCARE
    109. 6.109 HEALTHCARE, BY MATERIAL TYPE, 2024 (% SHARE)
    110. 6.110 HEALTHCARE, BY MATERIAL TYPE, 2024 TO 2035 (USD Billion)
    111. 6.111 HEALTHCARE, BY IMPLANT TYPE, 2024 (% SHARE)
    112. 6.112 HEALTHCARE, BY IMPLANT TYPE, 2024 TO 2035 (USD Billion)
    113. 6.113 HEALTHCARE, BY PATIENT AGE GROUP, 2024 (% SHARE)
    114. 6.114 HEALTHCARE, BY PATIENT AGE GROUP, 2024 TO 2035 (USD Billion)
    115. 6.115 HEALTHCARE, BY PRODUCT DESIGN, 2024 (% SHARE)
    116. 6.116 HEALTHCARE, BY PRODUCT DESIGN, 2024 TO 2035 (USD Billion)
    117. 6.117 BENCHMARKING OF MAJOR COMPETITORS
  7. 7 LIST OF TABLES
    1. 7.1 LIST OF ASSUMPTIONS
  8. 7.1.1
    1. 7.2 North America MARKET SIZE ESTIMATES; FORECAST
      1. 7.2.1 BY MATERIAL TYPE, 2025-2035 (USD Billion)
      2. 7.2.2 BY IMPLANT TYPE, 2025-2035 (USD Billion)
      3. 7.2.3 BY PATIENT AGE GROUP, 2025-2035 (USD Billion)
      4. 7.2.4 BY PRODUCT DESIGN, 2025-2035 (USD Billion)
    2. 7.3 US MARKET SIZE ESTIMATES; FORECAST
      1. 7.3.1 BY MATERIAL TYPE, 2025-2035 (USD Billion)
      2. 7.3.2 BY IMPLANT TYPE, 2025-2035 (USD Billion)
      3. 7.3.3 BY PATIENT AGE GROUP, 2025-2035 (USD Billion)
      4. 7.3.4 BY PRODUCT DESIGN, 2025-2035 (USD Billion)
    3. 7.4 Canada MARKET SIZE ESTIMATES; FORECAST
      1. 7.4.1 BY MATERIAL TYPE, 2025-2035 (USD Billion)
      2. 7.4.2 BY IMPLANT TYPE, 2025-2035 (USD Billion)
      3. 7.4.3 BY PATIENT AGE GROUP, 2025-2035 (USD Billion)
      4. 7.4.4 BY PRODUCT DESIGN, 2025-2035 (USD Billion)
    4. 7.5 Europe MARKET SIZE ESTIMATES; FORECAST
      1. 7.5.1 BY MATERIAL TYPE, 2025-2035 (USD Billion)
      2. 7.5.2 BY IMPLANT TYPE, 2025-2035 (USD Billion)
      3. 7.5.3 BY PATIENT AGE GROUP, 2025-2035 (USD Billion)
      4. 7.5.4 BY PRODUCT DESIGN, 2025-2035 (USD Billion)
    5. 7.6 Germany MARKET SIZE ESTIMATES; FORECAST
      1. 7.6.1 BY MATERIAL TYPE, 2025-2035 (USD Billion)
      2. 7.6.2 BY IMPLANT TYPE, 2025-2035 (USD Billion)
      3. 7.6.3 BY PATIENT AGE GROUP, 2025-2035 (USD Billion)
      4. 7.6.4 BY PRODUCT DESIGN, 2025-2035 (USD Billion)
    6. 7.7 UK MARKET SIZE ESTIMATES; FORECAST
      1. 7.7.1 BY MATERIAL TYPE, 2025-2035 (USD Billion)
      2. 7.7.2 BY IMPLANT TYPE, 2025-2035 (USD Billion)
      3. 7.7.3 BY PATIENT AGE GROUP, 2025-2035 (USD Billion)
      4. 7.7.4 BY PRODUCT DESIGN, 2025-2035 (USD Billion)
    7. 7.8 France MARKET SIZE ESTIMATES; FORECAST
      1. 7.8.1 BY MATERIAL TYPE, 2025-2035 (USD Billion)
      2. 7.8.2 BY IMPLANT TYPE, 2025-2035 (USD Billion)
      3. 7.8.3 BY PATIENT AGE GROUP, 2025-2035 (USD Billion)
      4. 7.8.4 BY PRODUCT DESIGN, 2025-2035 (USD Billion)
    8. 7.9 Russia MARKET SIZE ESTIMATES; FORECAST
      1. 7.9.1 BY MATERIAL TYPE, 2025-2035 (USD Billion)
      2. 7.9.2 BY IMPLANT TYPE, 2025-2035 (USD Billion)
      3. 7.9.3 BY PATIENT AGE GROUP, 2025-2035 (USD Billion)
      4. 7.9.4 BY PRODUCT DESIGN, 2025-2035 (USD Billion)
    9. 7.10 Italy MARKET SIZE ESTIMATES; FORECAST
      1. 7.10.1 BY MATERIAL TYPE, 2025-2035 (USD Billion)
      2. 7.10.2 BY IMPLANT TYPE, 2025-2035 (USD Billion)
      3. 7.10.3 BY PATIENT AGE GROUP, 2025-2035 (USD Billion)
      4. 7.10.4 BY PRODUCT DESIGN, 2025-2035 (USD Billion)
    10. 7.11 Spain MARKET SIZE ESTIMATES; FORECAST
      1. 7.11.1 BY MATERIAL TYPE, 2025-2035 (USD Billion)
      2. 7.11.2 BY IMPLANT TYPE, 2025-2035 (USD Billion)
      3. 7.11.3 BY PATIENT AGE GROUP, 2025-2035 (USD Billion)
      4. 7.11.4 BY PRODUCT DESIGN, 2025-2035 (USD Billion)
    11. 7.12 Rest of Europe MARKET SIZE ESTIMATES; FORECAST
      1. 7.12.1 BY MATERIAL TYPE, 2025-2035 (USD Billion)
      2. 7.12.2 BY IMPLANT TYPE, 2025-2035 (USD Billion)
      3. 7.12.3 BY PATIENT AGE GROUP, 2025-2035 (USD Billion)
      4. 7.12.4 BY PRODUCT DESIGN, 2025-2035 (USD Billion)
    12. 7.13 APAC MARKET SIZE ESTIMATES; FORECAST
      1. 7.13.1 BY MATERIAL TYPE, 2025-2035 (USD Billion)
      2. 7.13.2 BY IMPLANT TYPE, 2025-2035 (USD Billion)
      3. 7.13.3 BY PATIENT AGE GROUP, 2025-2035 (USD Billion)
      4. 7.13.4 BY PRODUCT DESIGN, 2025-2035 (USD Billion)
    13. 7.14 China MARKET SIZE ESTIMATES; FORECAST
      1. 7.14.1 BY MATERIAL TYPE, 2025-2035 (USD Billion)
      2. 7.14.2 BY IMPLANT TYPE, 2025-2035 (USD Billion)
      3. 7.14.3 BY PATIENT AGE GROUP, 2025-2035 (USD Billion)
      4. 7.14.4 BY PRODUCT DESIGN, 2025-2035 (USD Billion)
    14. 7.15 India MARKET SIZE ESTIMATES; FORECAST
      1. 7.15.1 BY MATERIAL TYPE, 2025-2035 (USD Billion)
      2. 7.15.2 BY IMPLANT TYPE, 2025-2035 (USD Billion)
      3. 7.15.3 BY PATIENT AGE GROUP, 2025-2035 (USD Billion)
      4. 7.15.4 BY PRODUCT DESIGN, 2025-2035 (USD Billion)
    15. 7.16 Japan MARKET SIZE ESTIMATES; FORECAST
      1. 7.16.1 BY MATERIAL TYPE, 2025-2035 (USD Billion)
      2. 7.16.2 BY IMPLANT TYPE, 2025-2035 (USD Billion)
      3. 7.16.3 BY PATIENT AGE GROUP, 2025-2035 (USD Billion)
      4. 7.16.4 BY PRODUCT DESIGN, 2025-2035 (USD Billion)
    16. 7.17 South Korea MARKET SIZE ESTIMATES; FORECAST
      1. 7.17.1 BY MATERIAL TYPE, 2025-2035 (USD Billion)
      2. 7.17.2 BY IMPLANT TYPE, 2025-2035 (USD Billion)
      3. 7.17.3 BY PATIENT AGE GROUP, 2025-2035 (USD Billion)
      4. 7.17.4 BY PRODUCT DESIGN, 2025-2035 (USD Billion)
    17. 7.18 Malaysia MARKET SIZE ESTIMATES; FORECAST
      1. 7.18.1 BY MATERIAL TYPE, 2025-2035 (USD Billion)
      2. 7.18.2 BY IMPLANT TYPE, 2025-2035 (USD Billion)
      3. 7.18.3 BY PATIENT AGE GROUP, 2025-2035 (USD Billion)
      4. 7.18.4 BY PRODUCT DESIGN, 2025-2035 (USD Billion)
    18. 7.19 Thailand MARKET SIZE ESTIMATES; FORECAST
      1. 7.19.1 BY MATERIAL TYPE, 2025-2035 (USD Billion)
      2. 7.19.2 BY IMPLANT TYPE, 2025-2035 (USD Billion)
      3. 7.19.3 BY PATIENT AGE GROUP, 2025-2035 (USD Billion)
      4. 7.19.4 BY PRODUCT DESIGN, 2025-2035 (USD Billion)
    19. 7.20 Indonesia MARKET SIZE ESTIMATES; FORECAST
      1. 7.20.1 BY MATERIAL TYPE, 2025-2035 (USD Billion)
      2. 7.20.2 BY IMPLANT TYPE, 2025-2035 (USD Billion)
      3. 7.20.3 BY PATIENT AGE GROUP, 2025-2035 (USD Billion)
      4. 7.20.4 BY PRODUCT DESIGN, 2025-2035 (USD Billion)
    20. 7.21 Rest of APAC MARKET SIZE ESTIMATES; FORECAST
      1. 7.21.1 BY MATERIAL TYPE, 2025-2035 (USD Billion)
      2. 7.21.2 BY IMPLANT TYPE, 2025-2035 (USD Billion)
      3. 7.21.3 BY PATIENT AGE GROUP, 2025-2035 (USD Billion)
      4. 7.21.4 BY PRODUCT DESIGN, 2025-2035 (USD Billion)
    21. 7.22 South America MARKET SIZE ESTIMATES; FORECAST
      1. 7.22.1 BY MATERIAL TYPE, 2025-2035 (USD Billion)
      2. 7.22.2 BY IMPLANT TYPE, 2025-2035 (USD Billion)
      3. 7.22.3 BY PATIENT AGE GROUP, 2025-2035 (USD Billion)
      4. 7.22.4 BY PRODUCT DESIGN, 2025-2035 (USD Billion)
    22. 7.23 Brazil MARKET SIZE ESTIMATES; FORECAST
      1. 7.23.1 BY MATERIAL TYPE, 2025-2035 (USD Billion)
      2. 7.23.2 BY IMPLANT TYPE, 2025-2035 (USD Billion)
      3. 7.23.3 BY PATIENT AGE GROUP, 2025-2035 (USD Billion)
      4. 7.23.4 BY PRODUCT DESIGN, 2025-2035 (USD Billion)
    23. 7.24 Mexico MARKET SIZE ESTIMATES; FORECAST
      1. 7.24.1 BY MATERIAL TYPE, 2025-2035 (USD Billion)
      2. 7.24.2 BY IMPLANT TYPE, 2025-2035 (USD Billion)
      3. 7.24.3 BY PATIENT AGE GROUP, 2025-2035 (USD Billion)
      4. 7.24.4 BY PRODUCT DESIGN, 2025-2035 (USD Billion)
    24. 7.25 Argentina MARKET SIZE ESTIMATES; FORECAST
      1. 7.25.1 BY MATERIAL TYPE, 2025-2035 (USD Billion)
      2. 7.25.2 BY IMPLANT TYPE, 2025-2035 (USD Billion)
      3. 7.25.3 BY PATIENT AGE GROUP, 2025-2035 (USD Billion)
      4. 7.25.4 BY PRODUCT DESIGN, 2025-2035 (USD Billion)
    25. 7.26 Rest of South America MARKET SIZE ESTIMATES; FORECAST
      1. 7.26.1 BY MATERIAL TYPE, 2025-2035 (USD Billion)
      2. 7.26.2 BY IMPLANT TYPE, 2025-2035 (USD Billion)
      3. 7.26.3 BY PATIENT AGE GROUP, 2025-2035 (USD Billion)
      4. 7.26.4 BY PRODUCT DESIGN, 2025-2035 (USD Billion)
    26. 7.27 MEA MARKET SIZE ESTIMATES; FORECAST
      1. 7.27.1 BY MATERIAL TYPE, 2025-2035 (USD Billion)
      2. 7.27.2 BY IMPLANT TYPE, 2025-2035 (USD Billion)
      3. 7.27.3 BY PATIENT AGE GROUP, 2025-2035 (USD Billion)
      4. 7.27.4 BY PRODUCT DESIGN, 2025-2035 (USD Billion)
    27. 7.28 GCC Countries MARKET SIZE ESTIMATES; FORECAST
      1. 7.28.1 BY MATERIAL TYPE, 2025-2035 (USD Billion)
      2. 7.28.2 BY IMPLANT TYPE, 2025-2035 (USD Billion)
      3. 7.28.3 BY PATIENT AGE GROUP, 2025-2035 (USD Billion)
      4. 7.28.4 BY PRODUCT DESIGN, 2025-2035 (USD Billion)
    28. 7.29 South Africa MARKET SIZE ESTIMATES; FORECAST
      1. 7.29.1 BY MATERIAL TYPE, 2025-2035 (USD Billion)
      2. 7.29.2 BY IMPLANT TYPE, 2025-2035 (USD Billion)
      3. 7.29.3 BY PATIENT AGE GROUP, 2025-2035 (USD Billion)
      4. 7.29.4 BY PRODUCT DESIGN, 2025-2035 (USD Billion)
    29. 7.30 Rest of MEA MARKET SIZE ESTIMATES; FORECAST
      1. 7.30.1 BY MATERIAL TYPE, 2025-2035 (USD Billion)
      2. 7.30.2 BY IMPLANT TYPE, 2025-2035 (USD Billion)
      3. 7.30.3 BY PATIENT AGE GROUP, 2025-2035 (USD Billion)
      4. 7.30.4 BY PRODUCT DESIGN, 2025-2035 (USD Billion)
    30. 7.31 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  9. 7.31.1
    1. 7.32 ACQUISITION/PARTNERSHIP
  10. 7.32.1

Healthcare Market Segmentation

Healthcare By Material Type (USD Billion, 2025-2035)

  • Metal
  • Ceramic
  • Plastic

Healthcare By Implant Type (USD Billion, 2025-2035)

  • Total Knee Replacement
  • Partial Knee Replacement
  • Patellofemoral Replacement

Healthcare By Patient Age Group (USD Billion, 2025-2035)

  • Under 30
  • 30-60
  • Over 60

Healthcare By Product Design (USD Billion, 2025-2035)

  • Fixed Bearing
  • Mobile Bearing
  • Cruciate Retaining